Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Other Accumulated Expenses (2016 - 2025)

Historic Other Accumulated Expenses for CorMedix (CRMD) over the last 11 years, with Q3 2025 value amounting to $278684.0.

  • CorMedix's Other Accumulated Expenses rose 4515.17% to $278684.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $278684.0, marking a year-over-year increase of 4515.17%. This contributed to the annual value of $122357.0 for FY2024, which is N/A changed from last year.
  • As of Q3 2025, CorMedix's Other Accumulated Expenses stood at $278684.0, which was up 4515.17% from $136298.0 recorded in Q2 2025.
  • CorMedix's Other Accumulated Expenses' 5-year high stood at $436290.0 during Q2 2024, with a 5-year trough of $54763.0 in Q3 2023.
  • For the 5-year period, CorMedix's Other Accumulated Expenses averaged around $134361.1, with its median value being $102998.0 (2021).
  • In the last 5 years, CorMedix's Other Accumulated Expenses soared by 30924.8% in 2024 and then plummeted by 6875.98% in 2025.
  • CorMedix's Other Accumulated Expenses (Quarter) stood at $94736.0 in 2021, then tumbled by 31.96% to $64456.0 in 2022, then dropped by 15.04% to $54763.0 in 2023, then skyrocketed by 123.43% to $122357.0 in 2024, then skyrocketed by 127.76% to $278684.0 in 2025.
  • Its Other Accumulated Expenses stands at $278684.0 for Q3 2025, versus $136298.0 for Q2 2025 and $87423.0 for Q1 2025.